Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Kathleen Packard to Purinergic P2Y Receptor Antagonists

This is a "connection" page, showing publications Kathleen Packard has written about Purinergic P2Y Receptor Antagonists.

 
Connection Strength
 
 
 
0.027
 
  1. DiNicolantonio JJ, Norgard NB, Meier P, Lavie CJ, O'Keefe JH, Niazi AK, Chatterjee S, Packard KA, D'Ascenzo F, Cerrato E, Biondi-Zoccai G, Bangalore S, Fuchs FD, Serebruany VL. Optimal aspirin dose in acute coronary syndromes: an emerging consensus. Future Cardiol. 2014 Mar; 10(2):291-300.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)